Co-Chairs
Britt Gayle, MD, MPH
Speakers
The 2025 RWHAP CLINICAL CONFERENCE will be in-person only. There will not be a virtual component.
This conference is specifically for clinical decision makers (MD/DOs, PAs, and NPs) in RWHAP-funded programs or clinics. A limited number of registration spots are available for registered nurses and pharmacists who serve as the primary decision makers in their respective RWHAP-funded programs or clinics.
This activity is eligible for CME credits, ABIM MOC points, AAFP credits, nursing credits, and pharmacist credits.
No mobile information will be shared with third parties/affiliates for marketing/promotional purposes.
The conference has reached full capacity, and the waitlist is closed. If you are already registered and will be unable to attend, please email registration@iasusa.org.
The 2025 Ryan White HIV/AIDS Program CLINICAL CONFERENCE will be held at the Capital Hilton in Washington, DC. We secured a conference rate of $189 per night for our attendees. To book your hotel stay, please click HERE. Details about the hotel and the surrounding areas can be found on the Hotel website. The last day to book your hotel is November 27, 2025, unless the hotel is fully booked before this date. Please note the hotel charges a 1-night rate as a deposit at the time of booking to secure your reservation. If you cancel at least 72 hours before your arrival date, the deposit will be refunded.
If the Capital Hilton is full, you can book a reservation at the Hyatt Place Washington DC/ White House, located just 300 feet from the venue, at a conference rate of $139 per night. To book your hotel stay, please click HERE. The deadline to book your reservation is December 5, 2025. Please note the hotel charges a 1-night rate as a deposit at the time of booking to secure your reservation. If you cancel at least 48 hours before your arrival date, the deposit will be refunded.
An email with important conference information will be sent on Monday, December 8. If you don’t receive it, please check your spam folder, then email registration@iasusa.org for a copy. If you can no longer attend, please email us. Please whitelist @iasusa.org to ensure you receive all future communications. If you need to update your profile, please log in to your IAS–USA account. We look forward to seeing you in Washington, DC!
Preliminary Agenda
Overview
2025 RWHAP CLINICAL CONFERENCE Description
The 2025 Ryan White HIV/AIDS Program (RWHAP) CLINICAL CONFERENCE will be held in-person in Washington, DC, from Sunday, December 14, to Tuesday, December 16. The RWHAP CLINICAL CONFERENCE will provide state-of-the-art updates on research, care, and treatment issues in the medical management of HIV infection for experienced HIV clinical decision makers.
Serving as co-chairs this year are Britt Gayle, MD, MPH, of the HIV/AIDS Bureau of the Health Resources and Services Administration in Rockville, Maryland; Jennifer W. Janelle, MD, of the University of Florida; and Michael S. Saag, MD, of the University of Alabama at Birmingham.
The 2025 RWHAP CLINICAL CONFERENCE is planned with and supported by the HIV/AIDS Bureau, Health Resources and Services Administration of the US Department of Health and Human Services (HRSA) and is sponsored and organized by the International Antiviral Society-USA (IAS-USA). This conference is coordinated through the National AETC Support Center clinician training network.
Participation of clinical decision makers from RWHAP-funded clinics and programs in this educational activity is an integral part of HRSA’s commitment to improving the care and enriching the lives of individuals with HIV. A mix of lectures, case-based interactive presentations, and small-group workshop breakout sessions will be held during the 3 days of the 2025 RWHAP CLINICAL CONFERENCE.
Who Should Attend
Attendance is specifically for HIV clinical decision makers, primarily physicians, nurse practitioners, and physician assistants in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs (specifically those operating under part A, B, C, and D), who are responsible for direct patient care and the decisions on clinical care and practice carried out at their clinics.
For those clinics that do not have clinical decision makers (MD/DOs, PAs, and NPs) or do not have one available at the time to participate, the 2025 RWHAP CLINICAL CONFERENCE offers a limited number of registration spots open specifically for pharmacists and registered nurses who play crucial roles in making clinical decisions within their respective RWHAP-funded clinics or programs.
A key element of the CLINICAL CONFERENCE and integral to HRSA’s commitment to supporting clinicians is that participants from RWHAP-funded clinics or programs are expected to provide relevant updates and training to their clinical colleagues who were unable to attend the conference. Comprehensive resources will be made available to facilitate the development of lectures and educational meetings after the conference.
Each RWHAP-funded clinic (whether through Part A, Part B, Part C, Part D, or a combination of any of these) may register up to 3 eligible staff members to attend.
There is no registration fee to attend.
If you selected to opt in to received text messages during the registration process, no mobile information will be shared with third parties/affiliates for marketing/promotional purposes.
Preliminary Learning Objectives
The educational objectives for the 2025 RWHAP CLINICAL CONFERENCE are designed and developed based on the identified needs and knowledge gaps of the attendees.
On completion of the 2025 RWHAP CLINICAL CONFERENCE, participants will be able to:
- Describe the new aspects and updates to the Ryan White HIV/AIDS Program
- Identify situations in which the choice of antiretroviral regimen should consider particular clinical circumstances, such as comorbid conditions, coinfections, pregnancy, and issues in older patients
- Describe the most current data on currently available and investigational new antiretroviral drugs, formulations, and strategies
- Initiate and monitor HIV prevention intervention strategies, including the use of long-acting injectable preexposure prophylaxis (PrEP), in individuals at risk for HIV infection
- Describe the current epidemiology, clinical presentations, and management of the most common sexually transmitted infections (STIs) in adults with HIV infection and in special populations such as adolescents
- Implement key primary care practices
- Implement the latest guideline recommendations for treatment, prevention, and management of common HIV-related OIs
Preliminary Topics
- Health Resources and Services Administration (HRSA) Ryan White HIV/AIDS program updates
- HIV cure
- New and investigational antiretroviral drugs and formulations
- Preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP)
- Difficult cases in antiretroviral therapy
- Metabolic complications, including diabetes, nonalcoholic fatty liver disease (NAFLD), visceral adiposity, and weight issues
- Cardiovascular issues in people with HIV
- Endocrine and hormonal imbalances in people with HIV, including management of menopause and male hypogonadism
- Preventative screening in HIV care, including anal cancer, bone frailty, and other cancers in primary care
- HIV and aging, with a focus on cognitive and neurologic complications
- Organ transplants in people with HIV
- Opportunistic infections
- Sexually transmitted infections (STIs), including syphilis
- Substance use and mental health disorders in people with HIV
- Recent changes in guidelines, new publications, and updates from recent conferences
IAS-USA Accreditation Statement
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. IAS-USA, the CME activity provider, will submit your participant information (eg, name, date of birth, activity credits earned, ABIM MOC number) to ABIM through the PARS system for the purpose of reporting ABIM MOC credits.
American Academy of Family Physicians Credits
The AAFP has reviewed The 2025 Ryan White HIV/AIDS Program CLINICAL CONFERENCE and deemed it acceptable for up to 16.50 Live AAFP Prescribed credit(s). Term of Approval is from 12/14/2025 to 12/16/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credits
Educational Review Systems is an approved approver of continuing nursing education by the ASNA, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider # 5-115. This program is approved for 16.25 hours of continuing nursing education.
Educational Review Systems is also approved for nursing continuing education by the state of California (Provider # 14692), the state of Florida and the District of Columbia.
Pharmacy Credits
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for up to 16.25 contact hours (1.625 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.
UAN #
0761-9999-25-224-L02-P
0761-9999-25-225-L02-P
0761-9999-25-226-L02-P
Conference Funding
This conference is funded by the Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number U10HA49824.